Debate on administration of magnesium sulfate to pregnant women to prevent cerebral palsy in preterm infants

June 29, 2009

New York, New York, June 29, 2009 - Cerebral palsy (CP) is the most prevalent chronic childhood motor disability with an estimated lifetime cost of nearly $1 million per individual. There is evidence that magnesium sulfate (MgSO4) can reduce the incidence of CP for very early preterm infants. Many thousands of pregnant women and their fetuses are exposed to MgSO4 every year in the United States for a variety of indications, and most obstetricians are comfortable with its use. Yet, there is still some controversy over whether magnesium sulfate is truly protective against CP. In three articles published in the June 2009 issue of the American Journal of Obstetrics & Gynecology, the authors shed some light on the debate.

Investigators from the Perinatology Research Branch (Division of Intramural Research), Eunice Kennedy Shriver National Institute of Child Health and Human Development, of the NIH, Bethesda, and Detroit, and the Center for Molecular Medicine and Genetics, Wayne State University, Detroit, conducted a systematic review and meta-analysis of six randomized controlled trials involving 4796 women and 5357 infants. Writing in the article, Dr. Roberto Romero and Dr. Agustin Conde-Agudelo concluded that "Antenatal magnesium sulfate should be considered for use in women at high risk of delivery before 34 weeks of gestation, mainly in those with premature rupture of membranes, labor in active phase, and planned delivery within 24 hours." They found persuasive evidence that administration of magnesium sulfate significantly reduces the risk of cerebral palsy in children at risk.

Continuing the debate, in an article summarizing a roundtable discussion at the 29th Annual Meeting of the Society for Maternal-Fetal Medicine, San Diego, CA, January 30, 2009, two researchers from the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Washington University-St. Louis,, and the Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California-San Francisco, enumerate the pros and cons of magnesium sulfate use for CP prevention. In a spirited conversation, they each talk about the available trials and observational studies and the strengths and weaknesses of each.

Participating in the roundtable, Alison G. Cahill, MD, MSCI, and Aaron B. Caughey, MD, PhD, observe, "Despite well-designed and executed studies, the answer to the question of whether evidence-based medicine supports the use of magnesium for neuroprophylaxis in all preterm pregnancies remains unclear."

Dwight J. Rouse, MD, of the Center for Women's Reproductive Health, University of Alabama at Birmingham, offers his clinical opinion on the use of MgSO4 to prevent cerebral palsy. He notes that "three large, randomized placebo-controlled trials of antenatal magnesium sulfate (MgSO4) for fetal neuroprotection have recently been conducted and reported. The results of these trials provide strong support for the utilization of MgSO4 to lower the risk of cerebral palsy among the survivors of early preterm birth. In the United States, the use of MgSO4 for fetal neuroprotection has the potential to prevent 1000 cases of handicapping cerebral palsy annually."
-end-
The articles are:

"Antenatal Magnesium Sulfate for the Prevention of Cerebral Palsy in Preterm Infants < 34 Weeks' Gestation: A Systematic Review and Meta-Analysis" by Agustín Conde-Agudelo, MD, MPH, and Roberto Romero, MD

"Magnesium for Neuroprophylaxis: Fact or Fiction?" by Alison G. Cahill, MD, MSCI, and Aaron B. Caughey, MD, PhD

"Magnesium Sulfate for the Prevention of Cerebral Palsy" by Dwight J. Rouse, MD

These contributions appear in the American Journal of Obstetrics & Gynecology, Volume 200, Issue 6 (June 2009) published by Elsevier.

Elsevier Health Sciences

Related Cerebral Palsy Articles from Brightsurf:

Study confirms genetic link in cerebral palsy
An international research team including the University of Adelaide has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder.

Cerebral palsy also has genetic underpinnings
Scientists have identified mutations in single genes that can be responsible for at least some cases of cerebral palsy, according to a new study led by researchers at Washington University School of Medicine in St.

About 14% of cerebral palsy cases may be tied to brain wiring genes
In an article published in Nature Genetics, NIH funded researchers confirm that about 14% of all cases of cerebral palsy, a disabling brain disorder for which there are no cures, may be linked to a patient's genes and suggest that many of those genes control how brain circuits become wired during early development.

How rehabilitation impacts research and care of patients with cerebral palsy
Cerebral palsy (CP) is one of the most common developmental movement disorders in children.

The risk of cerebral palsy linked to IVF has more than halved in the past two decades
Fifteen years ago a large population study from Denmark found a significantly increased risk of cerebral palsy in infants born as a result of assisted reproduction.

Orthotics breakthrough helps children with Cerebral Palsy walk and play
Children with Cerebral Palsy have more energy to play and be physically active for longer thanks to specially designed orthotics.

How a network of hospitals reduced average age at cerebral palsy diagnosis to 9.5 months
Five hospital systems in the United States have become the first in the world to successfully implement, in clinical practice, international CP diagnosis guidelines that were released in 2017.

Adults with cerebral palsy about twice as likely to develop non-communicable diseases
Adults with cerebral palsy are about twice as likely to develop cardiovascular disease and chronic respiratory disease compared to adults without cerebral palsy, according to a new study led by RCSI (Royal College of Surgeons in Ireland) and Brunel University London.

New insights: Improving function, independence and quality of life of individuals with cerebral palsy
Cerebral palsy (CP) is one of the most common movement disorders in children.

Adults with cerebral palsy at increased risk for mental health conditions
A new study finds that adults with cerebral palsy are at an increased risk of experiencing a mental health disorder compared to adults without the condition.

Read More: Cerebral Palsy News and Cerebral Palsy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.